BIOTECHNOLOGY EUROPE I BIOTECH EUROPE I PHARMA EUROPE - website solutions - OnLine Business Support for Biotechnology, Pharma and Chemical Industry targeting european market
 



   
      
   

Scientists engineer toxin-secreting stem cells to treat brain tumors

Harvard Stem Cell Institute scientists at Massachusetts General Hospital have devised a new way to use stem cells in the fight against brain cancer. A team led by neuroscientist Khalid Shah, MS, PhD, who recently demonstrated the value of stem cells loaded with cancer-killing herpes viruses, now has a way to genetically engineer stem cells so that they can produce and secrete tumor-killing toxins.

 
     
 

Understanding natural compounds

Medicine is drifting towards a major problem. An increasing number of bacteria is no longer sensitive to known antibiotics. Doctors urgently need to find new ways of fighting these multi-resistant pathogens. To address the problem, pharmaceutical research is turning back to the source of most of our drugs: nature.

 
     
  J&J brings its Care4today mobile adherence programme to the UK  
  Lilly invests in UK life sciences via biotech fund  
  GSK plans to sell off older products  
  AstraZeneca rejects Pfizer's final £69bn takeover bid  
  As Pfizer fights it out in Britain, US lawmakers are making their move in the long game  
     
   
 
 
 
 
 
 

Medigene significantly improves financial results for the first nine months of 2014 and achieves operational progress

 

 

 

Lytix Biopharma appoints Andrew Saunders, MD, FFPM, as Chief Medical Officer

 

 

 

Vetter Announces Opening of Office to Support Growing Asian Healthcare Market

 

 

 

Eleven More Countries Adopt  Cambridge Structural Database System National Provision

 

 

 

Clinical data of Medigene's Dendritic Cell vaccines to be presented at ASH conference

 

 

IntelliCap Oral Drug Delivery System Wins European Innovation Award Technology Opens Door to New Era of Smart Pharmaceutical Therapies

 

 
 

Cellmid Signs Evaluation and Option to License Agreement With Zoetis

 

 

 

Bionomics to Present BNC210 at Society for Neuroscience Meeting

 
   
   

 

FDA Approves Genentech’s Avastin (Bevacizumab) Plus Chemotherapy to Treat Women with Platinum-Resistant Recurrent Ovarian Cancer

 

 

 

Viralytics Receives UK Approval to Commence Clinical Trial of CAVATAK in Bladder Cancer

 

 

 

New Oncology to Collaborate with National Cancer Centre Singapore on Genetic Testing

 

 

 

New Management Organisation of the Haselmeier Group

 
   

 

Initial clinical data on Medigene's DC vaccines to be presented at the SITC Conference

 

 

 

Medigene's subsidiary "Trianta Immunotherapies" renamed "Medigene Immunotherapies"

 

 
 
 
 
  A new dent in HIV-1's armor

 

Like a slumbering dragon, HIV can lay dormant in a person’s cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.

 

Promising blood biomarkers identified for colorectal cancer: Is a screening blood test within reach?

 

The search for blood-borne biomarkers that could be used to screen for colorectal cancer (CRC) has uncovered two promising candidates that may one day lead to the development of a simple blood test.

Biosimilars one of the most promising segments of European pharma industry, says KuickResearch

 

Biosimilars are one of the most promising segments of the European pharma industry, according to a report by market research company KuickResearch. It found that the expiration of patents on blockbuster drugs, amenable regulatory framework and economic incentives have driven steady growth in the sector.

 
  A Cure for Ebola? These 3 Biotech Companies Are Working on It

 

Medical experts believe it was just a matter of time before Ebola made its way across the Atlantic to America. The first case in the U.S. was confirmed last week, and it's possible that there will be more cases in the future.

 

RCas9: A Programmable RNA Editing Tool

 

A powerful scientific tool for editing the DNA instructions in a genome can now also be applied to RNA, the molecule that translates DNA’s genetic instructions into the production of proteins. A team of researchers with Berkeley Lab and the University of California (UC) Berkeley...

Vitamin D significantly improves symptoms of winter-related atopic dermatitis in children

 

A study conducted in more than 100 Mongolian schoolchildren found that daily treatment with a vitamin D supplement significantly reduced the symptoms of winter-related atopic dermatitis, a type of eczema.

 
  Human genome was shaped by an evolutionary arms race with itself

 

New findings by scientists at the University of California, Santa Cruz, suggest that an evolutionary arms race between rival elements within the genomes of primates drove the evolution of complex regulatory networks that orchestrate the activity of genes in every cell of our bodies.

 
  Phosphate Increases The Concentration of Sodium (!) in The Blood

 

A previously undiscovered role played by the hormone FGF23 has now been discovered in a project funded by the Austrian Science Fund FWF. Scientists were already aware that greater quantities of this hormone are produced when there is too much phosphate in the blood plasma and that it reduces the absorption of this mineral from the urine.

 
  New enzyme targets for selective cancer therapies

 

Thanks to important discoveries in basic and clinical research and technological advances, the fight against cancer has mobilized into a complex offensive spanning multiple fronts. Work happening in a University of Alberta chemistry lab could help find...

   
 
 
 
Evaluation of ADMET Drug Properties in Drug Discovery and Development
27- 28 January 2015
  The course will describe scientific concepts and practice of ADME and toxicology studies in drug development, including preclinical in vitro and in vivo studies, clinical studies, IND and NDA submissions, and analytical chemistry.
 
     
 
     
  Sanner surpasses 55 million Euro mark  
  Sanner GmbH, a manufacturer of high quality plastic packaging and components for pharmaceutical, medical and healthcare products, topped the 55 million Euro mark and set a new sales record in 2013 (2012: 50.6 million Euro). This development was supported by a clear brand positioning with the new slogan "Sanner. Protecting Health" and substantial national and international investments.  
     
       
     
    Nanion Starts Shipping the SyncroPatch 384 Patch Engine – a Revolutionary Instrument for Giga-Seal, Automated Patch Clamp-Based Ion Channel Drug Screening  
   

The brand-new SyncroPatch 384 Patch Engine (PE) now released by Nanion Technologies propels ion channel drug discovery to a new level. Designed for seamless integration into process-automated drug screening environments, the Patch Engine is equipped with 384 patch clamp amplifiers and an advanced 384 channel liquid handling robot.

 
       
   
     
  AdiStem Announces PhotoActivated PRP Getting Superb Results on Joint Pain  
 

AdiStem Ltd., a provider of PhotoActivation Technology and medical solutions that assist in orthopedic, cosmetic, neurologic, pulmonary, metabolic and plastic/reconstructive surgery procedures, announces today that photoactivated PRP (Platelet Rich Plasma) prior to injection reduces pain and accelerates healing.

 
     
       
       
       
 
Evaluation of ADMET Drug Properties in Drug Discovery and Development
27- 28 January 2015
 
 
   
   
   
   
   
   
   
 
Ph.D in Molecular and Cellular Biology and Pathology
Business/ Clinical Director
Scientist
Senior Executive Human Resources
Looking for a PhD position or a job in any lab
Marketing and communications professional with intern experience in pharmaceutical marketing and drug development

Biological scientist with huge background in Molecular and Cellular Physiology

Bsc in Biomedical Engineering Technology
MSc in biotechnology
Scientific Officer
Regulatory associate
BSc R&D Biotechnology
M. Sc. in Biotechnology
Senior Scientist in Life Science
Scientific Officer
Research Scientist with over 10 years of interdisciplinary experience and expertise in molecular biology, virology, immunology and biochemistry
Post doctoral associate at Rockefeller University
Business Development Professional looking for employment in Belgium
Expertise in Plant Technologies and Conservation
Section Head
Business Development Professional
Highly talented Protein Biochemist
Ph.D. ( medical genetics )
Phd student in Nano-science center
 
 

 

  

        

logo down

                                                                                 office@biotechnology-europe.com I website@biotechnology-europe.com I service@biotechnology-europe.com

 


 

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

About Biotechnology Europe

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe


 

Biotechnology Europe Your Partner in Bioscience and Business

  Central Internet Platform and Service Company For The Life Sciences in Europe

Imprint I Site map I Privacy Policy I Contact us I About us I Copyright BIOTECHNOLOGY WORLD  All rights reserved